CC
Last reporting period 31 May, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.05
Exchange
XASE - Nyse MKT LLC
0.0015 B
Last period Cash and equivalents ,USD
-79%
Cash and equivalents has decreased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Cryo-Cell
Company Analysis
CCEL valuation, rating, competitors, insights and company profile
Eyestock Rating
CCEL financial analysis by Eyestock methodology
Valuation
CCEL valuation using historical relative method
Statements
CCEL Income Statements, Balance Sheet and Cash Flow Statements
Dividends
CCEL dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Cryo-Cell`s Cash and equivalents for the period ended 2024-05-31 are 0.0015 B USD
